Axcelis Technologies,Inc. (NASDAQ:ACLS) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

Barbara J. Lundberg, a member of the Board of Directors of Axcelis Technologies, Inc., died on January 21, 2017. Ms. Lundberg had been a Director since 2014 and served as chairman of the Audit Committee of the Company’s Board of Directors.

Due to the death of Ms. Lundberg, the Company’s Board of Directors currently consists of 7 independent directors and Ms. Puma, the Company’s chief executive officer. The Audit Committee currently consists of two independent directors. In the next weeks, the Board of Directors will set the number of seats for election at the 2017 annual meeting and will address the chairmanship and composition of the Audit Committee.

About Axcelis Technologies, Inc. (NASDAQ:ACLS)

Axcelis Technologies, Inc. designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company operates through the manufacture of capital equipment for the semiconductor manufacturing industry segment. The Company sells its equipment to semiconductor chip manufacturers across the world. In addition to equipment, it provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. The Company offers a line of high energy, high current and medium current implanters for various application requirements. Its other products include legacy dry strip equipment, curing systems and thermal processing systems. The Company’s systems are based on a Purion platform, which offers purity, precision and productivity by combining a single wafer end station, enabling unmatched throughput (approximately 500 wafers per hour), and a spot beam.

Axcelis Technologies, Inc. (NASDAQ:ACLS) Recent Trading Information

Axcelis Technologies, Inc. (NASDAQ:ACLS) closed its last trading session up +0.05 at 15.70 with 95,614 shares trading hands.